Spectrum of Chronic Kidney Disease Without Hemodialysis

Authors

  • Awais Elahi Ayub Teaching Hospital, Abbottabad, KP, Pakistan.
  • Haidar Zaman Ayub Teaching Hospital, Abbottabad, KP, Pakistan.
  • Ahsen Shah Ayub Teaching Hospital, Abbottabad, KP, Pakistan.
  • Jibran Pervaiz Ayub Teaching Hospital, Abbottabad, KP, Pakistan.
  • Bilal Rabani Abbas Institute of Medical Sciences (AIMS) Hospital, Muzaffarabad, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i7.2679

Keywords:

Chronic Kidney Disease, Diabetes Mellitus, Hepatitis C Virus, Hypertension.

Abstract

Background: Chronic Kidney Disease is an irreversible process where the deterioration of the kidneys progresses, making it impossible to extract the wastes and fluid from the bloodstream, which further gives rise to various complications. The common factors promoting the advancement of CKD are diabetes mellitus, high blood pressure, and Hepatitis C infections. Effective management of comorbid conditions delays the progress of CKD. This research work focuses on the spectrum of CKD without hemodialysis and how comorbidities influence patients from the region of Abbottabad. Objective: To determine the frequency of spectrum of chronic kidney disease in patients without hemodialysis. Study Design: Cross-sectional study. Duration and Place of Study: This study was conducted from 26th March 2025 to 26th June 2025 at the Department of Nephrology, Ayub Teaching Hospital, Abbottabad. Methodology: Ninety patients aged 30 to 60 years, already diagnosed with CKD, were recruited. Information on demographics, comorbid conditions, and CKD stages was gathered. Diagnosis of diabetes involved fasting blood sugar and clinical history, and for hypertension, patients were confirmed if their BP was ≥ 140/90mmHg. Hepatitis C diagnosis involved the use of the PCR test. Analysis of the study was conducted using the IBM SPSS version 25 computer software program, and association was determined by the chi-squared test, where the significance level was p < 0.05. Results: The mean age of participants were 45.81 ± 9.03 years and the average BMI was 27.74 ± 2.71 kg/m². Diabetes mellitus was found in 32.2% patients, hypertension 31.1% and Hepatitis C virus was 15.6%. A significant association was observed between hypertension and female gender (p  0.011). The majority of patients were in Stage 3 of CKD (65.6%). Conclusion: Diabetes and hypertension are prevalent comorbidities among CKD patients, with hypertension showing a significant association with female gender.

Downloads

Download data is not yet available.

References

1. Coimbra, S., & Santos-Silva, A. (2025). New Advances in Chronic Kidney Disease: Biology, Diagnosis and Therapy. Biomedicines, 13(2), 518–518.

https://doi.org/10.3390/biomedicines13020518

2. Li, Y., Chen, Y., Nie, J., Huang, X., & Zhang, W. (2025). Case report: Sympathetic nerve block treat chronic kidney disease-associated pruritus. Frontiers in Neuroscience, 19.

https://doi.org/10.3389/fnins.2025.1529183

3. Duggal, V., Thomas, I., Montez-Rath, M. E., Chertow, G. M., & Kurella Tamura, M. (2021). National estimates of CKD prevalence and potential impact of estimating glomerular filtration rate without race. Journal of the American Society of Nephrology, 32(6), 1454-1463.

https://doi.org/10.1681/asn.2020121780

4. He, J., Wang, X., Zhu, P., Wang, X., Zhang, Y., Zhao, J., Sun, W., Hu, K., He, W., & Xie, J. (2025). Identification and validation of an explainable early-stage chronic kidney disease prediction model: A multicenter retrospective study. eClinicalMedicine, 84, 103286.

https://doi.org/10.1016/j.eclinm.2025.103286

5. Zhang, X., Zhang, J., Ren, Y., Sun, R., & Zhai, X. (2024). Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: Insights from panvascular diseases. Frontiers in Endocrinology, 15.

https://doi.org/10.3389/fendo.2024.1368481

6. Zahra, S., Saleem, M. K., Ejaz, K. F., Akbar, A., Jadoon, S. K., Hussain, S., Ali, A. I., Ifty, M., Jannati, S. Z., Armin, F., Sarker, D., Islam, D. Z., Khandker, S. S., Khan, M. S., & Alvi, S. (2024). Prevalence of nephropathy among diabetic patients in North American region: A systematic review and meta-analysis. Medicine, 103(38), e39759.

https://doi.org/10.1097/md.0000000000039759

7. He, Y., Tang, W., Chen, J., Tang, J., Zheng, Y., Wang, X., Xing, B., Li, X., Xu, Y., & Wang, X. (2025). Global burden of chronic kidney disease due to hypertension (1990–2021): A systematic analysis of epidemiological trends, risk factors, and projections to 2036 from the GBD 2021 study. BMC Nephrology, 26(1).

https://doi.org/10.1186/s12882-025-04386-8

8. Kumar, M., Dev, S., Khalid, M. U., Siddenthi, S. M., Noman, M., John, C., Akubuiro, C., Haider, A., Rani, R., Kashif, M., Varrassi, G., Khatri, M., Kumar, S., & Mohamad, T. (2023). The bidirectional link between diabetes and kidney disease: Mechanisms and management. Cureus.

https://doi.org/10.7759/cureus.45615

9. Ferdman, L., Jensen, H., Hazaa, A., & Donnell, R. W. (2024). An aggressive case of Cryoglobulinemia and Membranoproliferative Glomerulonephritis: A case report. Cureus.

https://doi.org/10.7759/cureus.62193

10. Kale, A., Shelke, V., Dagar, N., Anders, H., & Gaikwad, A. B. (2023). How to use COVID-19 antiviral drugs in patients with chronic kidney disease. Frontiers in Pharmacology, 14.

https://doi.org/10.3389/fphar.2023.1053814

11. Pethő, Á. G., Tapolyai, M., Csongrádi, É., & Orosz, P. (2024). Management of chronic kidney disease: The current novel and forgotten therapies. Journal of Clinical & Translational Endocrinology, 36, 100354.

https://doi.org/10.1016/j.jcte.2024.100354

12. Aguilar-Ramirez, D., Alegre-Díaz, J., Gnatiuc, L., Ramirez-Reyes, R., Wade, R., Hill, M., Collins, R., Peto, R., Emberson, J. R., Herrington, W. G., Kuri-Morales, P., & Tapia-Conyer, R. (2021). Changes in the diagnosis and management of diabetes in Mexico City between 1998–2004 and 2015–2019.

https://doi.org/10.2337/figshare.13607792

13. Reddy, T. K., Nasser, S. A., Pulapaka, A. V., Gistand, C. M., & Ferdinand, K. C. (2024). Tackling the disproportionate burden of resistant hypertension in US Black adults. Current Cardiology Reports, 26(11), 1163-1171.

https://doi.org/10.1007/s11886-024-02115-5

14. Zhang, M., Han, Z., Lin, Y., Jin, Z., Zhou, S., Wang, S., Tang, Y., Li, J., Li, X., & Chen, H. (2024). Understanding the relationship between HCV infection and progression of kidney disease. Frontiers in Microbiology, 15.

https://doi.org/10.3389/fmicb.2024.1418301

15. Sadek, K. M., Zayed, B. M., Eldeeb, M. M., Ahmed, D. H., Aly, A. A., & Belal, D. M. (2017). Spectrum of kidney diseases in patients presented for acute hemodialysis in Kasr Al-Aini School of Medicine. Saudi Journal of Kidney Diseases and Transplantation, 28(4), 860-868.

https://journals.lww.com/sjkd/fulltext/2017/28040/Spectrum_of_Kidney_Diseases_in_Patients_Presented.19.aspx

16. MacRae, C., Mercer, S. W., Guthrie, B., & Henderson, D. (2020). Comorbidity in chronic kidney disease: A large cross-sectional study of prevalence in Scottish primary care. British Journal of General Practice, 71(704), e243-e249.

https://doi.org/10.3399/bjgp20x714125

17. Gutiérrez Sánchez, D., & Leiva-Santos, J. P. (2021). Síntomas, comorbilidad Y estado funcional de los pacientes con enfermedad renal crónica estadio 5 en manejo renal conservador. Enfermería Global, 20(3), 33-54.

https://doi.org/10.6018/eglobal.449531

18. Bălan, D. G., Filip Calangiu, Tănase, G., Tulin, R., Isac, S., Georgescu, D. E., Dorin Dragoș, Cobilinschi, C., Chiperi, L. V., Ionescu, D., Balcangiu-Stroescu, A. E., Călinoiu, A. L., Rusu, A., & Văcăroiu, I. A. (2023). Etiology of Chronic Kidney Disease and Comorbidities in Chronic Hemodialysis Patients. Romanian Journal of Military Medicine, 126(2), 153–159.

https://doi.org/10.55453/rjmm.2023.126.2.5

19. Gurukkal, C. M. K., & Bithun, B. K. (2018). Comorbidities and their management in patients with chronic kidney disease in a tertiary hospital of Kerala. INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY, 6(1), 151-154.

20. Bilal, M. S., Anwar, S., Ahmad, S., Ahmad, S., Iqbal, Z., & Azhar, U. (2025). Frequency of Intradialytic complications among patients of maintenance hemodialysis on thrice weekly. Pakistan Journal of Health Sciences, 02-07.

https://doi.org/10.54393/pjhs.v6i9.3376

21. Nasuuna, E. M., Tomlinson, L. A., Kalyesubula, R., Castelnuovo, B., Nanyeenya, N., Dziva Chikwari, C., & Weiss, H. A. (2024). Comorbidities associated with chronic kidney disease among young people living with HIV in Uganda. A nested case control study.

https://doi.org/10.1101/2024.11.14.24317307

22. Alssageer, M. A., Saad, M. M., & Mosbah, O. M. (2023). Prevalence of comorbidities, polypharmacy and drug-related problems among hospitalized patients with chronic kidney disease. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences, 3(1), 51-63.

http://dx.doi.org/10.5281/zenodo.7771698

23. Trbojevic-Stankovic J. Approaching the patient with CKD and associated comorbidities: how to choose the right treatment? Summary report – Nephrology Education Portal. 2022. Available from:

https://www.nephrologyeducationportal.com.

24. Holstiege J, Kohring C, Dammertz L. (2024). Comorbidity in chronic kidney disease in German outpatient care. Versorgungsatlas-Report. 24/04.

Downloads

Published

2025-07-20

How to Cite

Elahi , A., Zaman, H., Shah, A., Pervaiz, J., & Rabani, B. (2025). Spectrum of Chronic Kidney Disease Without Hemodialysis. Indus Journal of Bioscience Research, 3(7), 1419-1423. https://doi.org/10.70749/ijbr.v3i7.2679